FDA approves Barium Sulfate
The FDA has approved the use of E-Z-HD barium sulfate for use in patients 12 years old and up. Read More »
The FDA has approved the use of E-Z-HD barium sulfate for use in patients 12 years old and up. Read More »
The FDA has made progress on its Action Plan, published in August of 2015, to improve participation in clinical trials. Read More »
The Department of Justice, on behalf of the FDA, filed a consent decree for permanent injunction against Dallas-based compounding pharmacy Downing Labs late last week. Read More »
The National Institute of Allergy and Infectious Diseases has donated $5 million to fund 24 research projects designed to cultivate therapeutic alternatives to traditional antibiotics. Read More »
The Food and Drug Administration (FDA) is warning health-care professionals and patients that dosing errors have occurred when switching between two different oral formulations of Noxafil. Read More »
Sanofi and Regeneron Pharmaceuticals Inc. announced last week that the U.S. Food and Drug Administration (FDA) will review their Biologics License Application for sarilumab, an antibody that will help treat patients with moderate-to-severe rheumatoid arthritis. Read More »
Zoll Manufacturing Corporation's LifeVest wearable defibrillator was approved by the Food and Drug Administration (FDA) Dec. 17 for children at risk of sudden cardiac arrest. Read More »
The Fenix Continence Restoration System was approved by the U.S. Food and Drug Administration Dec. 18. Read More »
Recent laboratory analysis conducted by the Food and Drug Administration (FDA) confirms that the herbal weight loss dietary supplement La’Trim Plus contains undeclared controlled substance sibutramine and chemical phenolphthalein. Read More »
The Food and Drug Administration (FDA) granted approval Monday for Uptravi, a new oral IP prostacyclin receptor agonist medication to treat adults with pulmonary arterial hypertension (PAH). Read More »
An area pharmacist, a physician employee in Georgia and two Kentucky women were allegedly involved in a highly orchestrated pharmaceutical drug syndicate in West Virginia. Read More »
The American Society of Health-System Pharmacists (ASHP) and the Accreditation Council for Pharmacy Education (ACPE) recently modified accreditation standards for pharmacy technician education and training programs. Read More »
A recent hearing of the U.S. Senate Special Committee on Aging in Washington, D.C., discussed price increases on non-patented prescription drugs. Read More »
The American Society of Health-System Pharmacists (ASHP) presented six of its members with Distinguished Service Awards Monday. Read More »
The Centers for Medicaid and Medicare Services (CMS) released its annual National Health Expenditures report for 2014 on Wednesday. Read More »
The American Society of Health System Pharmacists released the "NICU Primer for Pharmacists" to help neonatal caregivers understand the medicine they are giving to patients. Treating neonatal patients is often complex and complicated, so medicating them requires a deep understanding of pharmaceuticals to give to these fragile patients. Dr. Amy Holmes wrote the published work. Read More »
Bristol-Myers Squibb's drug Empliciti was approved by the Food and Drug Administration (FDA) Monday as a combination treatment for multiple myeloma, a form of blood cancer. Read More »
Eli Lilly and Co.'s drug Portrazza was approved by the Food and Drug Administration (FDA) Nov. 24 as a combination treatment for advanced squamous non-small cell lung cancer (NSCLC). Read More »
National Community Pharmacist Association (NCPA) President Bradley Arthur provided testimony Nov. 17 on the dominating power that large pharmacy benefit management (PBM) corporations have on the pharmaceutical marketplace. Read More »
More than 200 members of the American Society of Health-System Pharmacists (ASHP) recently approved three professional policies at the organization's inaugural virtual House of Delegates. Read More »